Cytokinetics Inc. buy Barclays PLC
Start price
23.05.24
/
50%
€46.40
Target price
23.05.25
€87.72
Performance (%)
12.07%
Price
30.08.24
€52.00
Summary
This prediction is currently active. The prediction currently has a performance of 12.07%. This prediction currently runs until 23.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 0.971% | 0.971% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Barclays PLC from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat